Centocor Inc said it entered intoan agreement with &lt;Ajinomoto Co Inc> for the exclusivedistribution of Centocor's Panorex in Japan.    Panorex is a monoclonal antibody, made through recombinantgene technology, for the treatment of pancreatic cancer. It hasbeen tested in humans in Europe and the U.S. since 1982.Centocor said it intends to begin clinical trials in the U.S.this year with a modified form of the drug.    Under the agreement, Ajinomoto will conduct clinical testsof the drug in Japan and both companies will jointly file formarketing approval for the product in Japan. Reuter&#3;